{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T21:45:26Z","timestamp":1778190326340,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013327","name":"H. Lundbeck A\/S","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.parkreldis.2021.05.008","type":"journal-article","created":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T21:56:36Z","timestamp":1620683796000},"page":"105-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Comparing subjective and objective response to medications in Parkinson's disease patients using the Personal KinetiGraph\u2122"],"prefix":"10.1016","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4138-3696","authenticated-orcid":false,"given":"Erik","family":"Krause","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaskaren","family":"Randhawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1704-3683","authenticated-orcid":false,"given":"Raja","family":"Mehanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2021.05.008_bib1","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","article-title":"Projected number of people with Parkinson disease in the most populous nations 2005 through 2030","volume":"68","author":"Dorsey","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2021.05.008_bib2","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.parkreldis.2013.07.002","article-title":"Poor self-awareness of levodopa-induced dyskinesias in Parkinson's disease: clinical features and mechanisms","volume":"19","author":"Pietracupa","year":"2013","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2021.05.008_bib3","doi-asserted-by":"crossref","unstructured":"A. Levit, C. Zebendon, L. Walter, P. O'Donnell, C. Marras, Communication gaps about OFF periods between physicians and patients with Parkinson's disease: a patient\u2013physician dialogue analysis, Res. Rev. Parkinsonism, 2019 (2019) 38.","DOI":"10.2147\/JPRLS.S188923"},{"key":"10.1016\/j.parkreldis.2021.05.008_bib4","series-title":"The Profile of the Hospitalized and Re-hospitalized Parkinson Disease Patients: 5 Year Data from the National Parkinson Foundation Quality Improvement Initiative","author":"Shangholi","year":"2015"},{"key":"10.1016\/j.parkreldis.2021.05.008_bib5","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/17434440.2017.1349608","article-title":"Evaluation of the Parkinson's KinetiGraph in monitoring and managing Parkinson's disease","volume":"14","author":"Farzanehfar","year":"2017","journal-title":"Expet Rev. Med. Dev."},{"key":"10.1016\/j.parkreldis.2021.05.008_bib6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3233\/JPD-181373","article-title":"Qualitative evaluation of the personal KinetiGraph movement recording system in a Parkinson's clinic","volume":"9","author":"Santiago","year":"2019","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.parkreldis.2021.05.008_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.17925\/ENR.2014.09.01.27","article-title":"Can objective measurements improve treatment outcomes in Parkinson's disease?","volume":"9","author":"Bergquist","year":"2014","journal-title":"Eur. Neurol. Rev."},{"key":"10.1016\/j.parkreldis.2021.05.008_bib8","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/mds.27671","article-title":"Movement Disorder Society Task Force on Technology, A roadmap for implementation of patient-centered digital outcome measures in Parkinson's disease obtained using mobile health technologies","volume":"34","author":"Espay","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.05.008_bib9","unstructured":"Press release: CE mark awarded to second generation PKG\u2122 system. [cited 2018 May 1]. Available from: Error! Hyperlink reference not valid."},{"key":"10.1016\/j.parkreldis.2021.05.008_bib10","author":"Press release"},{"key":"10.1016\/j.parkreldis.2021.05.008_bib11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev-bioeng-062117-121036","article-title":"New sensor and wearable technologies to aid in the diagnosis and treatment monitoring of Parkinson's disease","author":"Monje","year":"2019","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.parkreldis.2021.05.008_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124522","article-title":"An objective fluctuation score for Parkinson's disease","volume":"10","author":"Horne","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.parkreldis.2021.05.008_bib13","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3233\/JPD-160898","article-title":"An ambulatory tremor score for Parkinson's disease","volume":"6","author":"Braybrook","year":"2016","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.parkreldis.2021.05.008_bib14","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.parkreldis.2014.02.011","article-title":"Daytime Sleep in Parkinson's Disease measured by episodes of immobility","volume":"20","author":"Kotschet","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2021.05.008_bib16","first-page":"16","article-title":"The clinical validation of objective measurement of movement in Parkinson's disease","volume":"1","author":"Horne","year":"2016","journal-title":"Oruen \u2013 CNS J."},{"key":"10.1016\/j.parkreldis.2021.05.008_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41531-018-0046-4","article-title":"Objective measurement in routine care of people with Parkinson's disease improves outcomes","volume":"3","author":"Farzanehfar","year":"2018","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.parkreldis.2021.05.008_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161559","article-title":"Correlation of quantitative motor state assessment using a kinetograph and patient diaries in advanced PD: data from an observational study","volume":"11","author":"Ossig","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.parkreldis.2021.05.008_bib19","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/mds.27673","article-title":"MDS technology Task Force and the MDS rating scales program electronic development ad-hoc committee, the Parkinson's disease e-diary: developing a clinical and research tool for the digital age","volume":"34","author":"Vizcarra","year":"2019","journal-title":"Mov. Disord."},{"issue":"suppl 2","key":"10.1016\/j.parkreldis.2021.05.008_bib20","article-title":"Costs and outcomes for Parkinson's disease patient who have their management adjusted by Personal KinetiGraph (PKG)","volume":"33","author":"Lynch","year":"2018","journal-title":"Mov. Diosrd."},{"issue":"suppl 2","key":"10.1016\/j.parkreldis.2021.05.008_bib21","article-title":"Objective Data in Parkinson's Disease: a description of over 20,000 Parkinson's symptom scores across the world using the Personal KinetiGraph (PKG) [abstract]","volume":"33","author":"Lynch","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.05.008_bib22","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1080\/14737175.2018.1503948","article-title":"Role of the Personal KinetiGraph in the routine clinical assessment of Parkinson's disease: recommendations from an expert panel","volume":"18","author":"Pahwa","year":"2018","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.parkreldis.2021.05.008_bib23","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/mds.21360","article-title":"Predicting the cost of Parkinson's disease","volume":"22","author":"McCrone","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.05.008_bib24","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1468-1331.2005.01096.x","article-title":"Trial Study Group Effects of dyskinesias in Parkinson's disease on quality of life and health-related costs: a prospective European study","volume":"12","author":"P\u00e9chevis","year":"2005","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.parkreldis.2021.05.008_bib25","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3111\/13696998.2010.551164","article-title":"The economic burden of advanced Parkinson's disease: an analysis of a UK patient dataset","volume":"12","author":"J Findley","year":"2011","journal-title":"J. Med. Econ."},{"key":"10.1016\/j.parkreldis.2021.05.008_bib26","first-page":"13","article-title":"Interpreting health economics data in Parkinson's disease","volume":"6","author":"Dodel","year":"2011","journal-title":"Eur. Neurol. Rev."},{"key":"10.1016\/j.parkreldis.2021.05.008_bib27","unstructured":"P. Farzanehfar, M. Baybrook, K. Kotschet, M. Horne, Objective Measurement in Clinical Care of Patients with Parkinson's Disease: an RCT Using the PKG, Unpublished poster presentation at IMDS 2016, June 19-23 2016, Berlin Germany."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021001711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021001711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:22:46Z","timestamp":1761178966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802021001711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":26,"alternative-id":["S1353802021001711"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.05.008","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing subjective and objective response to medications in Parkinson's disease patients using the Personal KinetiGraph\u2122","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}